Sökning: id:"swepub:oai:DiVA.org:uu-501623" >
Risk and location o...
Risk and location of distant metastases in patients with locally advanced rectal cancer after total neoadjuvant treatment or chemoradiotherapy in the RAPIDO trial
-
- Bahadoer, Renu R. (författare)
- Leiden Univ, Dept Surg, Med Ctr, Albinusdreef 2,Postbus 9600, NL-2300 RC Leiden, Netherlands.
-
- Hospers, Geke A. P. (författare)
- Univ Med Ctr Groningen, Dept Med Oncol, Hanzepl 1,Postbus 30-001, NL-9700 RB Groningen, Netherlands.;Univ Med Ctr Groningen, Dept Med Oncol, Hanzepl 1,Postbus 30-001, NL-9700 RB Groningen, Netherlands.
-
- Marijnen, Corrie A. M. (författare)
- Netherlands Canc Inst, Dept Radiat Oncol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.;Leiden Univ, Dept Radiat Oncol, Med Ctr, Albinusdreef 2,Postbus 9600, NL-2300 RC Leiden, Netherlands.
-
visa fler...
-
- Peeters, Koen C. M. J. (författare)
- Leiden Univ, Dept Surg, Med Ctr, Albinusdreef 2,Postbus 9600, NL-2300 RC Leiden, Netherlands.
-
- Putter, Hein (författare)
- Leiden Univ, Dept Med Stat & Bioinformat, Med Ctr, Albinusdreef 2,Postbus 9600, NL-2300 RC Leiden, Netherlands.
-
- Dijkstra, Esmee A. (författare)
- Univ Med Ctr Groningen, Dept Med Oncol, Hanzepl 1,Postbus 30-001, NL-9700 RB Groningen, Netherlands.
-
- Kranenbarg, Elma Meershoek-Klein (författare)
- Leiden Univ, Dept Surg, Med Ctr, Albinusdreef 2,Postbus 9600, NL-2300 RC Leiden, Netherlands.
-
- Roodvoets, Annet G. H. (författare)
- Leiden Univ, Dept Surg, Med Ctr, Albinusdreef 2,Postbus 9600, NL-2300 RC Leiden, Netherlands.
-
- van Etten, Boudewijn (författare)
- Univ Med Ctr Groningen, Dept Surg, Hanzepl 1,Postbus 30-001, NL-9700 RB Groningen, Netherlands.
-
- Nilsson, Per J. (författare)
- Karolinska Institutet
-
- Glimelius, Bengt (författare)
- Uppsala universitet,Cancerprecisionsmedicin
-
- van de Velde, Cornelis J. H. (författare)
- Leiden Univ, Dept Surg, Med Ctr, Albinusdreef 2,Postbus 9600, NL-2300 RC Leiden, Netherlands.
-
, ollaborative investigators (författare)
-
visa färre...
-
Leiden Univ, Dept Surg, Med Ctr, Albinusdreef 2,Postbus 9600, NL-2300 RC Leiden, Netherlands Univ Med Ctr Groningen, Dept Med Oncol, Hanzepl 1,Postbus 30-001, NL-9700 RB Groningen, Netherlands.;Univ Med Ctr Groningen, Dept Med Oncol, Hanzepl 1,Postbus 30-001, NL-9700 RB Groningen, Netherlands. (creator_code:org_t)
- Elsevier, 2023
- 2023
- Engelska.
-
Ingår i: European Journal of Cancer. - : Elsevier. - 0959-8049 .- 1879-0852. ; 185, s. 139-149
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://uu.diva-port... (primary) (Raw object)
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Introduction: Although optimising rectal cancer treatment has reduced local recurrence rates, many patients develop distant metastases (DM). The current study investigated whether a total neoadjuvant treatment strategy influences the development, location, and timing of metastases in patients diagnosed with high-risk locally advanced rectal cancer included in the Rectal cancer And Pre-operative Induction therapy followed by Dedicated Operation (RAPIDO) trial.Material and methods: Patients were randomly assigned to short-course radiotherapy fol-lowed by 18 weeks of CAPOX or FOLFOX4 before surgery (EXP), or long-course che-moradiotherapy with optional postoperative chemotherapy (SC-G). Assessments for metastatic disease were performed pre-and post-treatment, during surgery, and 6, 12, 24, 36, and 60 months postoperatively. From randomisation, differences in the occurrence of DM and first site of metastasis were evaluated.Results: In total, 462 patients were evaluated in the EXP and 450 patients in the SC-G groups. The cumulative probability of DM at 5 years after randomisation was 23% [95% CI 19-27] and 30% [95% CI 26-35] (HR 0.72 [95% CI 0.56-0.93]; P = 0.011) in the EXP and SC -G, respectively. The median time to DM was 1.4 (EXP) and 1.3 years (SC-G). After diagnosis of DM, median survival was 2.6 years [95% CI 2.0-3.1] in the EXP and 3.2 years [95% CI 2.3-4.1] in the SC-G groups (HR 1.39 [95% CI 1.01-1.92]; P = 0.04). First occurrence of DM was most often in the lungs (60/462 [13%] EXP and 55/450 [12%] SC-G) or the liver (40/462 [9%] EXP and 69/450 [15%] SC-G). A hospital policy of postoperative chemotherapy did not influence the development of DM.Conclusions: Compared to long-course chemoradiotherapy, total neoadjuvant treatment with short-course radiotherapy and chemotherapy significantly decreased the occurrence of me-tastases, particularly liver metastases.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kirurgi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Surgery (hsv//eng)
Nyckelord
- Rectal cancer
- Total neoadjuvant therapy
- Distant metastases
- Metastatic pattern
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Bahadoer, Renu R ...
-
Hospers, Geke A. ...
-
Marijnen, Corrie ...
-
Peeters, Koen C. ...
-
Putter, Hein
-
Dijkstra, Esmee ...
-
visa fler...
-
Kranenbarg, Elma ...
-
Roodvoets, Annet ...
-
van Etten, Boude ...
-
Nilsson, Per J.
-
Glimelius, Bengt
-
van de Velde, Co ...
-
, ollaborative i ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kirurgi
- Artiklar i publikationen
-
European Journal ...
- Av lärosätet
-
Uppsala universitet
-
Karolinska Institutet